Geron new CEO

John Scarlett is Geron's new CEO. He has 25 years of executive leadership.  A Biotechnology Industry Veteran Brings Extensive Track Record of Drug Development and Commercialization Success.

Conference Call/Webcast Scheduled for 9:00 A.M. ET Tomorrow

This is great news there will be no more secondary stock of offerings. Maybe at $20+. Mr. Scarlett          would not take the job unless he saw a great opportunity. Again I feel this is a great move by Geron.       

Good luck in this rigged casino